Home Multimedia Podcasts ADVANCES IN DRUG DELIVERY AND TISSUE ENGINEERING ADVANCES IN DRUG DELIVERY AND TISSUE ENGINEERING April 10, 2008 – Interview with Robert Langer, Ph.D., Institute Professor, Chemical and Biomedical Engineering, MIT /wp-content/uploads/2018/09/gc198_4_10_2008.mp3 PodcastsResourcesBrain cancerCancersDrug deliveryGenetic engineeringGenetic Engineering and BiotechnologyMedicine, Diagnosis, and TherapeuticsNanoparticlesNanotechnologyPharmacologyRegenerative engineeringSystemic conditionsTechnology and Computational BiologyTissue engineering Also of Interest Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap AI Screening of Pediatric Cancers Improves Treatment Outcomes China Upholds Key CVC CRISPR Patent Licensed through ERS Genomics Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline Related Media AACR 2024: A Video Update from San Diego Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World Related Content Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap AI Screening of Pediatric Cancers Improves Treatment Outcomes
